ENG/中
老虎證券
行情
交易
收費
下載
優惠與活動
幫助
TigerAI
學堂
機構
財富及資產管理人
自營交易機構
介紹經紀商
三方服務商
股權激勵
關於
關於我們
媒體報道
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
Medicus Pharma Ltd.
0.4852
-0.0185
-3.67%
盤前：
0.4797
-0.0055
-1.13%
09:26 EDT
成交量：
303.07萬
成交額：
144.83萬
市值：
1,239.69萬
市盈率：
-0.21
高：
0.5032
開：
0.4804
低：
0.4521
收：
0.5037
52周最高：
8.94
52周最低：
0.3700
股本：
2,555.00萬
流通股本：
1,719.51萬
量比：
0.08
換手率：
17.63%
股息：
- -
股息率：
- -
每股收益(TTM):
-2.3103
每股收益(LYR):
-1.1597
淨資產收益率：
-2660.81%
總資產收益率：
-170.69%
市淨率：
-13.62
市盈率(LYR):
-0.42
資料載入中...
總覽
公司
新聞資訊
公告
Siga Technologies Inc.盤中異動 股價大跌5.17%報5.50美元
市场透视
·
03/09
Prf Technologies Ltd.盤中異動 急速跳水8.00%報2.53美元
市场透视
·
03/06
Medicus Pharma公布二期Sknjct-003試驗積極頂線數據：200微克組第57天實現73%臨床清除率與40%組織學清除率
美股速递
·
03/05
美國OTC市場Gsk Plc盤中異動 股價大跌5.77%
市场透视
·
02/23
Medicus Pharma Ltd.盤中異動 下午盤大幅拉升5.45%報1.16美元
市场透视
·
02/21
Medicus Pharma Ltd.盤中異動 急速下跌5.83%
市场透视
·
02/11
Medicus Pharma獲FDA批准Teverelix®針對高心血管風險晚期前列腺癌患者的IIb期研究可繼續進行
美股速递
·
02/10
BUZZ-削減teverelix特許權使用費後，Medicus Pharma股價上漲
路透中文
·
01/22
Medicus Pharma Ltd.修訂協議未改變授權範圍、核心知識產權及雙方開發職責
美股速递
·
01/22
Medicus Pharma Ltd. 宣佈修訂Lifearc許可協議，優化Teverelix®長期經濟與開發前景
美股速递
·
01/22
Medicus Pharma Ltd. 於12月29日與Maxim Group及Yorkville Securities簽署股權分銷協議 - 美國證券交易委員會文件披露
美股速递
·
2025/12/30
Medicus Pharma Ltd.與Reliant AI簽署非約束性意向書，合作開發AI驅動的數據分析平台
美股速递
·
2025/12/22
Medicus Pharma Ltd.任命Carolyn Bonner為首席財務官，同時擔任總裁職位
美股速递
·
2025/12/01
Medicus Pharma Ltd.盤中異動 股價大漲5.03%
市场透视
·
2025/11/22
Medicus Pharma Ltd. 宣佈提交FDA專員國家優先券申請（Cnpv），以非侵入性方式治療皮膚基底細胞癌（Bcc）
美股速递
·
2025/11/17
Medicus Pharma Ltd.宣佈與Gorlin綜合症聯盟合作，推動Skinject™的同情使用途徑，針對Gorlin綜合症患者
美股速递
·
2025/10/29
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣0平台費、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣0平台費、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/MDCX/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"MDCX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MDCX\",,,,,undefined,":{"symbol":"MDCX","market":"US","secType":"STK","nameCN":"Medicus Pharma Ltd.","latestPrice":0.4852,"timestamp":1773259200000,"preClose":0.5037,"halted":0,"volume":3030689,"hourTrading":{"tag":"盘前","latestPrice":0.4797,"preClose":0.4852,"latestTime":"09:26 EDT","volume":78003,"amount":37102.3297578,"timestamp":1773321983647,"change":-0.0055,"changeRate":-0.011336,"amplitude":0.029885},"delay":0,"changeRate":-0.03672821123684736,"floatShares":17195100,"shares":25549983,"eps":-2.310262,"marketStatus":"盤前交易","change":-0.0185,"latestTime":"03-12 09:26:32 EDT","open":0.4804,"high":0.5032,"low":0.4521,"amount":1448274.3219957398,"amplitude":0.101449,"askPrice":0.48,"askSize":150,"bidPrice":0.4,"bidSize":600,"shortable":0,"etf":0,"ttmEps":-2.310262,"tradingStatus":1,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1773322200000},"marketStatusCode":1,"adr":0,"listingDate":1731560400000,"exchange":"NASDAQ","adjPreClose":0.4852,"preHourTrading":{"tag":"盘前","latestPrice":0.4797,"preClose":0.4852,"latestTime":"09:26 EDT","volume":78003,"amount":37102.3297578,"timestamp":1773321983647,"change":-0.0055,"changeRate":-0.011336,"amplitude":0.029885},"postHourTrading":{"tag":"盘后","latestPrice":0.4684,"preClose":0.4852,"latestTime":"19:58 EDT","volume":119904,"amount":56321.603607,"timestamp":1773273521022,"change":-0.0168,"changeRate":-0.034625,"amplitude":0.064509},"volumeRatio":0.07862911586961772},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MDCX\",,,,,undefined,":{"symbol":"MDCX","floatShares":17195100,"roa":"-170.69%","roe":"-2660.81%","lyrEps":-1.159715,"volumeRatio":0.07862911586961772,"shares":25549983,"dividePrice":0,"high":0.5032,"amplitude":0.101449,"preClose":0.5037,"low":0.4521,"week52Low":0.37,"pbRate":"-13.62","week52High":8.94,"institutionHeld":0,"latestPrice":0.4852,"committee":0.6,"eps":-2.310262,"divideRate":0,"volume":3030689,"delay":0,"ttmEps":-2.310262,"open":0.4804,"prevYearClose":1.53,"fiveDayClose":1.38,"twentyDayClose":1.03,"sixtyDayClose":1.95},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MDCX\",params:#limit:5,,,undefined,":[{"date":"2025-11-14","symbol":"MDCX","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1763154000000,"name":null,"time":"盤後","dateTimestamp":1763096400000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MDCX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MDCX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":3,"updateTime":1744689600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/MDCX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"MDCX","date":"2026-03-11","current":-0.210019,"percent":0.985294,"low":-3.23298,"twenty":-2.845022,"median":-1.28141,"eighty":-0.931212,"high":-0.276791,"avg":-1.741526,"sd":0.893343,"marketCap":14865739},"quantilePoints":[{"date":"2025-08-29","current":-2.084531,"twenty":-2.272139,"median":-2.126221,"eighty":-2.109545,"marketCap":35632532},{"date":"2025-09-05","current":-1.907346,"twenty":-2.205434,"median":-2.115799,"eighty":-2.053263,"marketCap":32603766},{"date":"2025-09-12","current":-2.345097,"twenty":-2.211687,"median":-2.12101,"eighty":-2.053263,"marketCap":40086598},{"date":"2025-09-19","current":-2.532705,"twenty":-2.511859,"median":-2.178335,"eighty":-2.080362,"marketCap":43293526},{"date":"2025-09-26","current":-2.817408,"twenty":-2.759151,"median":-2.287772,"eighty":-2.103292,"marketCap":48160186},{"date":"2025-10-03","current":-3.005474,"twenty":-2.869667,"median":-2.511859,"eighty":-2.115799,"marketCap":51374941},{"date":"2025-10-10","current":-3.005474,"twenty":-2.994879,"median":-2.558762,"eighty":-2.122052,"marketCap":51374941},{"date":"2025-10-17","current":-2.885734,"twenty":-2.976858,"median":-2.720313,"eighty":-2.151236,"marketCap":49328130},{"date":"2025-10-24","current":-2.909682,"twenty":-2.974342,"median":-2.774974,"eighty":-2.174166,"marketCap":49737492},{"date":"2025-10-31","current":-2.957578,"twenty":-2.974342,"median":-2.817408,"eighty":-2.178335,"marketCap":50556216},{"date":"2025-11-07","current":-2.897708,"twenty":-2.962368,"median":-2.809662,"eighty":-2.228364,"marketCap":49532811},{"date":"2025-11-14","current":-2.706124,"twenty":-2.950394,"median":-2.817408,"eighty":-2.292984,"marketCap":46257915},{"date":"2025-11-21","current":-1.28141,"twenty":-2.950394,"median":-2.789942,"eighty":-2.178335,"marketCap":44939453},{"date":"2025-11-28","current":-1.355609,"twenty":-2.936025,"median":-2.763,"eighty":-2.119968,"marketCap":48464116},{"date":"2025-12-05","current":-1.183077,"twenty":-2.916866,"median":-2.742046,"eighty":-2.04284,"marketCap":42295956},{"date":"2025-12-12","current":-1.201563,"twenty":-2.904892,"median":-2.700137,"eighty":-1.376181,"marketCap":42956830},{"date":"2025-12-19","current":-1.022869,"twenty":-2.897708,"median":-2.63428,"eighty":-1.31987,"marketCap":36568379},{"date":"2025-12-26","current":-0.955088,"twenty":-2.897553,"median":-2.584818,"eighty":-1.266827,"marketCap":34145173},{"date":"2026-01-02","current":-1.074791,"twenty":-2.896932,"median":-2.511859,"eighty":-1.220048,"marketCap":38424640},{"date":"2026-01-09","current":-1.095865,"twenty":-2.885734,"median":-2.329463,"eighty":-1.179996,"marketCap":39178064},{"date":"2026-01-16","current":-0.976444,"twenty":-2.885734,"median":-2.178335,"eighty":-1.123965,"marketCap":34908660},{"date":"2026-01-23","current":-0.94132,"twenty":-2.866576,"median":-2.167912,"eighty":-1.101485,"marketCap":33652952},{"date":"2026-01-30","current":-0.878097,"twenty":-2.861786,"median":-2.115799,"eighty":-1.061072,"marketCap":31392680},{"date":"2026-02-06","current":-0.765701,"twenty":-2.861786,"median":-2.074108,"eighty":-1.022014,"marketCap":27374416},{"date":"2026-02-13","current":-0.709738,"twenty":-2.853549,"median":-1.933403,"eighty":-0.974021,"marketCap":25373688},{"date":"2026-02-20","current":-0.786136,"twenty":-2.850483,"median":-1.381324,"eighty":-0.961937,"marketCap":28104981},{"date":"2026-02-27","current":-0.97195,"twenty":-2.849812,"median":-1.344224,"eighty":-0.949581,"marketCap":34747976},{"date":"2026-03-06","current":-0.484474,"twenty":-2.849812,"median":-1.300152,"eighty":-0.949581,"marketCap":17320333},{"date":"2026-03-11","current":-0.415816,"twenty":-2.845022,"median":-1.28141,"eighty":-0.931212,"marketCap":14865739}],"updateTime":1773321992101},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MDCX\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2618953047","title":"Siga Technologies Inc.盤中異動 股價大跌5.17%報5.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2618953047","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618953047?lang=zh_tw&edition=fundamental","pubTime":"2026-03-09 22:00","pubTimestamp":1773064835,"startTime":"0","endTime":"0","summary":"北京时间2026年03月09日22时00分，Siga Technologies Inc.股票出现波动，股价急速下挫5.17%。截至发稿，该股报5.50美元/股，成交量7.3733万股，换手率0.10%，振幅3.28%。Siga Technologies Inc.股票所在的制药行业中，整体跌幅为0.82%。Siga Technologies Inc.公司简介：西佳科技有限公司是一家专注于健康安全市场的商业阶段制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026030922003695461cf2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026030922003695461cf2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4583","BK4139","BK4007","SIGA","MDCX"],"gpt_icon":0},{"id":"2617658389","title":"Prf Technologies Ltd.盤中異動 急速跳水8.00%報2.53美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2617658389","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617658389?lang=zh_tw&edition=fundamental","pubTime":"2026-03-06 22:59","pubTimestamp":1772809178,"startTime":"0","endTime":"0","summary":"北京时间2026年03月06日22时59分，Prf Technologies Ltd.股票出现异动，股价急速跳水8.00%。截至发稿，该股报2.53美元/股，成交量2434股，换手率0.31%，振幅4.91%。Prf Technologies Ltd.股票所在的制药行业中，整体跌幅为1.85%。Prf Technologies Ltd.公司简介：PainReform Ltd是一家多元化的平台型企业，涵盖特种制药、药物输送技术以及基于人工智能的可再生能源分析等领域。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260306225938a6ab4be6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260306225938a6ab4be6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","PRFX","MDCX"],"gpt_icon":0},{"id":"1177064497","title":"Medicus Pharma公布二期Sknjct-003試驗積極頂線數據：200微克組第57天實現73%臨床清除率與40%組織學清除率","url":"https://stock-news.laohu8.com/highlight/detail?id=1177064497","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1177064497?lang=zh_tw&edition=fundamental","pubTime":"2026-03-05 20:33","pubTimestamp":1772714036,"startTime":"0","endTime":"0","summary":"Medicus Pharma Ltd.近日披露了其二期临床试验Sknjct-003的顶线研究结果，数据表现亮眼。在200微克剂量组中，第57天的评估显示，患者达到73%的临床清除率，同时组织学清除率也达到40%。这一数据为后续临床开发提供了有力支持。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MDCX"],"gpt_icon":0},{"id":"2613518237","title":"美國OTC市場Gsk Plc盤中異動 股價大跌5.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2613518237","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613518237?lang=zh_tw&edition=fundamental","pubTime":"2026-02-23 22:51","pubTimestamp":1771858316,"startTime":"0","endTime":"0","summary":"北京时间2026年02月23日22时51分，美国OTC市场Gsk Plc股票出现波动，股价急速跳水5.77%。截至发稿，该股报29.40美元/股，成交量970股，换手率0.00%，振幅0.00%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。美国OTC市场Gsk Plc股票所在的制药行业中，整体涨幅为1.91%。美国OTC市场Gsk Plc公司简介：在制药行业，葛兰素史克是总销售额最大的公司之一。葛兰素史克利用合资企业在艾滋病毒等特定市场获得额外的规模。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202602232251569541aee0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202602232251569541aee0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MDCX","BK4139","GLAXF","BK4007"],"gpt_icon":0},{"id":"2613398217","title":"Medicus Pharma Ltd.盤中異動 下午盤大幅拉升5.45%報1.16美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2613398217","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613398217?lang=zh_tw&edition=fundamental","pubTime":"2026-02-21 04:03","pubTimestamp":1771617797,"startTime":"0","endTime":"0","summary":"北京时间2026年02月21日04时03分，Medicus Pharma Ltd.股票出现波动，股价急速拉升5.45%。Medicus Pharma Ltd.股票所在的制药行业中，整体跌幅为0.71%。Medicus Pharma Ltd.公司简介：Medicus Pharma Ltd是一家临床阶段的控股公司，专注于通过经美国食品药品监督管理局批准的临床试验，投资和推动新型生命科学和生物技术公司的发展。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026022104031797a6970e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026022104031797a6970e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MDCX"],"gpt_icon":0},{"id":"2610232921","title":"Medicus Pharma Ltd.盤中異動 急速下跌5.83%","url":"https://stock-news.laohu8.com/highlight/detail?id=2610232921","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610232921?lang=zh_tw&edition=fundamental","pubTime":"2026-02-11 23:01","pubTimestamp":1770822106,"startTime":"0","endTime":"0","summary":"北京时间2026年02月11日23时01分，Medicus Pharma Ltd.股票出现异动，股价快速跳水5.83%。Medicus Pharma Ltd.股票所在的制药行业中，整体涨幅为0.03%。Medicus Pharma Ltd.公司简介：Medicus Pharma Ltd是一家临床阶段的控股公司，专注于通过经美国食品药品监督管理局批准的临床试验，投资和推动新型生命科学和生物技术公司的发展。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260211230147a6ef7f82&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260211230147a6ef7f82&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MDCX","BK4139"],"gpt_icon":0},{"id":"1179126983","title":"Medicus Pharma獲FDA批准Teverelix®針對高心血管風險晚期前列腺癌患者的IIb期研究可繼續進行","url":"https://stock-news.laohu8.com/highlight/detail?id=1179126983","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1179126983?lang=zh_tw&edition=fundamental","pubTime":"2026-02-10 20:30","pubTimestamp":1770726624,"startTime":"0","endTime":"0","summary":"Medicus Pharma Ltd. 宣布，其用于治疗伴有高心血管风险的晚期前列腺癌患者的Teverelix® IIb期临床试验，已获得美国食品药品监督管理局（FDA）的“研究可继续进行”许可。这一监管里程碑意味着公司可以按计划推进该临床阶段的研究工作。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MDCX"],"gpt_icon":0},{"id":"2605994374","title":"BUZZ-削減teverelix特許權使用費後，Medicus Pharma股價上漲","url":"https://stock-news.laohu8.com/highlight/detail?id=2605994374","media":"路透中文","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605994374?lang=zh_tw&edition=fundamental","pubTime":"2026-01-22 21:04","pubTimestamp":1769087043,"startTime":"0","endTime":"0","summary":"BUZZ-削减teverelix特许权使用费后，Medicus Pharma股价上涨1月22日 - ** 药物开发商Medicus Pharma MDCX.O股价盘前上涨12%至1.49美元 ** 该公司表示，在修订与英国研究机构LifeArc的协议后，已将前列腺癌试验药物teverelix的专利使用费从~4%降至2%。** 公司的 teverelix 正在接受晚期前列腺癌和复发性急性尿潴留的测试。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260122:nL4S3YN128:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MDCX"],"gpt_icon":0},{"id":"1184034229","title":"Medicus Pharma Ltd.修訂協議未改變授權範圍、核心知識產權及雙方開發職責","url":"https://stock-news.laohu8.com/highlight/detail?id=1184034229","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1184034229?lang=zh_tw&edition=fundamental","pubTime":"2026-01-22 20:33","pubTimestamp":1769085202,"startTime":"0","endTime":"0","summary":"Medicus Pharma Ltd. 近日宣布，其对现有协议的修订并未对原授权协议的范围、基础知识产权归属或合作双方各自的开发责任产生任何实质性改变。此次修订旨在优化合作条款，确保项目推进效率，同时维持原有知识产权框架与开发义务的稳定性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MDCX","BK4139"],"gpt_icon":0},{"id":"1127677442","title":"Medicus Pharma Ltd. 宣佈修訂Lifearc許可協議，優化Teverelix®長期經濟與開發前景","url":"https://stock-news.laohu8.com/highlight/detail?id=1127677442","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1127677442?lang=zh_tw&edition=fundamental","pubTime":"2026-01-22 20:31","pubTimestamp":1769085098,"startTime":"0","endTime":"0","summary":"Medicus Pharma Ltd. 已宣布对其与Lifearc达成的许可协议进行修订。此次修订旨在显著提升其核心产品Teverelix®的长期经济价值和开发潜力。协议的调整预计将为该药物的未来商业化道路带来更有利的条件。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MDCX","BK4139"],"gpt_icon":0},{"id":"1151832941","title":"Medicus Pharma Ltd. 於12月29日與Maxim Group及Yorkville Securities簽署股權分銷協議 - 美國證券交易委員會文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1151832941","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1151832941?lang=zh_tw&edition=fundamental","pubTime":"2025-12-30 22:29","pubTimestamp":1767104953,"startTime":"0","endTime":"0","summary":"根据一份提交至美国证券交易委员会的文件，Medicus Pharma Ltd. 已于12月29日与Maxim Group及Yorkville Securities正式达成股权分销协议。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MDCX","BK4139"],"gpt_icon":0},{"id":"1121701858","title":"Medicus Pharma Ltd.與Reliant AI簽署非約束性意向書，合作開發AI驅動的數據分析平台","url":"https://stock-news.laohu8.com/highlight/detail?id=1121701858","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1121701858?lang=zh_tw&edition=fundamental","pubTime":"2025-12-22 20:39","pubTimestamp":1766407152,"startTime":"0","endTime":"0","summary":"Medicus Pharma Ltd.与Reliant AI签署非约束性意向书，合作开发AI驱动的数据分析平台","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MDCX"],"gpt_icon":0},{"id":"1132984225","title":"Medicus Pharma Ltd.任命Carolyn Bonner為首席財務官，同時擔任總裁職位","url":"https://stock-news.laohu8.com/highlight/detail?id=1132984225","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1132984225?lang=zh_tw&edition=fundamental","pubTime":"2025-12-01 20:32","pubTimestamp":1764592329,"startTime":"0","endTime":"0","summary":"Medicus Pharma Ltd.任命Carolyn Bonner为首席财务官，同时担任总裁职位","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MDCX"],"gpt_icon":0},{"id":"2585176113","title":"Medicus Pharma Ltd.盤中異動 股價大漲5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2585176113","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585176113?lang=zh_tw&edition=fundamental","pubTime":"2025-11-22 04:27","pubTimestamp":1763756825,"startTime":"0","endTime":"0","summary":"北京时间2025年11月22日04时27分，Medicus Pharma Ltd.股票出现异动，股价急速上涨5.03%。Medicus Pharma Ltd.股票所在的制药行业中，整体涨幅为1.83%。Medicus Pharma Ltd.公司简介：Medicus Pharma Ltd是一家临床阶段的控股公司，专注于通过经美国食品药品监督管理局批准的临床试验，投资和推动新型生命科学和生物技术公司的发展。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025112204270695134297&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025112204270695134297&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MDCX","BK4139"],"gpt_icon":0},{"id":"1175699912","title":"Medicus Pharma Ltd. 宣佈提交FDA專員國家優先券申請（Cnpv），以非侵入性方式治療皮膚基底細胞癌（Bcc）","url":"https://stock-news.laohu8.com/highlight/detail?id=1175699912","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1175699912?lang=zh_tw&edition=fundamental","pubTime":"2025-11-17 20:31","pubTimestamp":1763382674,"startTime":"0","endTime":"0","summary":"Medicus Pharma Ltd. 宣布提交FDA专员国家优先券申请（Cnpv），以非侵入性方式治疗皮肤基底细胞癌（Bcc）。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MDCX","BK4139"],"gpt_icon":0},{"id":"1193933872","title":"Medicus Pharma Ltd.宣佈與Gorlin綜合症聯盟合作，推動Skinject™的同情使用途徑，針對Gorlin綜合症患者","url":"https://stock-news.laohu8.com/highlight/detail?id=1193933872","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1193933872?lang=zh_tw&edition=fundamental","pubTime":"2025-10-29 19:32","pubTimestamp":1761737537,"startTime":"0","endTime":"0","summary":"Medicus Pharma Ltd.宣布与Gorlin综合症联盟合作，推动Skinject™的同情使用途径，针对Gorlin综合症患者","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MDCX","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":16,"code":"91000000","status":"200"}]}}